Sanofi's "Chris Viehbacher, who’s completed 32 acquisitions and 91 licensing deals in four years..."
91 license deals means this is a proven, viable, profitable way forward for Sanofi. SOP. It does not mean the candidate is dead. By no means whatsoever. If Big Red stays on the pipe, it is a big win. If we hear news, it even bigger. If FOV1101 remains on the pipe, it won't be long.
The Fovea patent tells us there may be other indications for a Big Red injections.